INTRODUCTION
The oral route of drug delivery in general is considered the favourite means of drug administration. Conventional drug delivery systems for controlled release are based on single or multiple unit reservoir or matrix system. These are design to deliver constant drug levels over an extended period of time. Pulsatile systems are basically time controlled drug delivery systems which are designed to mimic the circadian rhythm of the body and deliver the drug at a specific time (after a programmed lag phase) as the pathophysiological conditions of disease required, resulting in improvement of patient compliance and therapeutic efficacy [1] [2] [3] [4] [5] .
Need for study:
Diabetes mellitus (DM) is characterized by high levels of blood glucose due to defects in insulin production, insulin action, or both. Type-II DM (non-insulin dependent diabetes mellitus) occurs due to insulin resistance and relative insulin deficiency. Oral sulfonylurea's therapy remains a cornerstone for the treatment of diabetes. Sulfonylurea's acts through insulin release by inhibiting the K ATP channel of the pancreatic ß-cells. Glipizide belongs to sulfonylurea class and is an oral rapid-and short-acting anti-diabetic drug. It is an effective oral anti-diabetic (100 times more potent than Tolbutamide in evoking pancreatic secretion of insulin) [6] [7] [8] . Owing to its short biological half life (3.4 ± 0.7 h), there is an urgent need of such a delivery system which can overcome its multidosing per day through delayed release and extended half life. Thus, development of multiunit pulsatile dosage form would be the advantageous.
Glipizide was obtained as a gift sample from USV Ltd, Baddi. Ethyl cellulose and croscarmellose were procured from HiMedia Laboratories Pvt. Ltd., Mumbai. Eudragit S-100 and L-100 were obtained as a gift sample from Evonik Degussa India Private Limited, Mumbai. Disodium hydrogen phosphate, potassium dihydrogen phosphate, acetone, chloroform, petroleum ether and nHexane were purchased from Merck India Pvt. Ltd., Mumbai. Guar gum, PVP, cellulose acetate phthalate, sodium hydroxide was purchased from CDH (P) Ltd., New Delhi. Lactose, magnesium stearate, sodium chloride, span-80 and tween-80 were procured from Loba Chemie Pvt. Ltd., Mumbai.
Preparation of impermeable capsule body 9,10 :
Hard gelatin capsules of size 0 were taken 50 in number. Their bodies were separated from the caps. 25 ml of 15% v/v formaldehyde was taken into desiccator and a pinch of KMnO 4 was added, to generate formalin vapours. The desiccator was tightly closed. The reaction was conducted for 12 hours; after which the capsule bodies were removed. The capsule bodies were dried for 30 minutes at 50°C to ensure the completion of reaction between gelatin and formaldehyde vapours. To facilitate removal of residual formaldehyde the bodies were then dried at room temperature. Tests like identification attributes (transparency, lockable type, odour, nature), visual defects, dimensions and solubility studies of the treated capsules were conducted on prepared impermeable capsule body.
Preparation of microspheres of Glipizide:
Microspheres were prepared by using emulsificationsolvent evaporation method. Accurately weighed 1 gm polymer (Ethyl cellulose/Eudragit L-100:S-100) was dissolved in 100 ml of solvent (Chloroform/Acetone) to form a homogenous polymer solution. Core material, i.e. Glipizide was added to the polymer solution and mixed thoroughly. This organic phase was slowly poured into continuous phase (200 ml of aqueous phase containing emulsifier i.e. 0.5 %w/v of Sodium CMC / 200 ml of liquid paraffin) containing 1% w/w of surfactant (Tween-80/Span-80) with stirring at 1000 rpm to form a smooth emulsion. Thereafter, it was allowed to reach room temperature and stirring was continued until residual chloroform/acetone was evaporated and smooth-walls, rigid and discrete microspheres were formed. The microspheres were collected by decantation and the product was washed with water/petroleum ether (40-60°C), four times and dried at room temperature for 3 hours. The microspheres were then stored in a desiccator over fused calcium chloride. Microspheres were evaluated for particle size (using optical microscopy), flow properties, surface morphology (SEM), percentage practical yield and percentage drug content. To carry out drug content, in a 100 ml volumetric flask microspheres equivalent to 10mg of Glipizide were taken and the volume was made up to mark with pH 6.8 phosphate buffer. The flask was shaken for 12 hours using a mechanical shaker. Then the solution was filtered and appropriate dilutions were made from the filtrate and absorbance was measured at 226 nm. 
Preparation of glipizide bilayered tablet plug:
Bilayered tablet plugs of glipizide were prepared by the direct compression method.
Formulation of the fast release layer:
The dose of the formulation for fast release was 5mg. The polymers, drug and other excipients for fast releasing layers were passed through sieve #60 before their use in the formulation. The blend is mixed properly.
Formulation of erodible tablet layer:
The formulations containing 16, 20 and 30% of Guar gum were prepared and excipients like lactose was added up to 99%. Each formulation was mixed for 10 minutes, followed by addition of 1% magnesium stearate to each blend. The resultant blends were mixed for 5 minutes. Glipizide  5  5  5  5  5  5  5  5  5  5  5  5  MCC  ---86  85  84  ---86  85  84  ---86  85  84  Croscarmellose  sodium ---- 
Compression of bilayered tablet plugs:
The blends of erodible tablet plug containing 16, 20 and 30% of Guar Gum were separately compressed lightly using a Rotary Tablet Compression Machine using 6.5 mm round, flat and plain punches. Over this compressed layer, required quantity of the fast release layer containing drug was placed and compressed (hardness in the range of 4.5-5.5 kg/cm 2 ) to form a Glipizide Bilayered Tablet Plugs. The composition of all formulations is provided in table 2.
Pre-compression Studies were conducted. Compressed bilayered tablet plugs were evaluated for parameters like hardness, weight variation, uniformity of thickness, friability test, erosion time, percentage drug content and in vitro drug release studies.
Assembly of pulsatile drug delivery system containing glipizide 11,12 :
Figure 1: Overview of designed pulsatile device
A chronomodulated Pulsatile (modified pulsincap) drug delivery system containing Glipizide Bilayer Tablet and Glipizide microspheres was prepared for the timecontrolled release of both drugs in combination.
Overview of designed pulsatile device is shown in Figure 01 .
Procedure for assembly of pulsatile (modified pulsincap) drug delivery system:
Formaldehyde treated hard gelatin capsules of size '0' were chosen for the formulation. The bodies and caps were separated manually. Microspheres equivalent to 10 mg of Glipizide and lactose was filled in capsule body and then plugged with bilayered tablet plugs containing Guar Gum of various compositions and then capped with soluble gelatin cap. The whole system thus produced is modified pulsincap.
Glipizide bilayered tablet plug containing fast releasing layer (5 mg glipizide and five percent croscarmellose sodium as super disintegrant) and erodible tablet layer containing 16%, 20% and 30% of Guar Gum has been used for preparing pulsatile (modified pulsincap) drug delivery system containing Glipizide microspheres (equivalent to 10 mg).
In bilayered tablet layer, there will be fast release of Glipizide (5 mg) followed by a slow erodible polymer (guar gum). Sampling was stopped after 0.5 hours (i.e. after release of Glipizide from fast releasing layer) and again started 0.5 hours before the expelling time of plugs (i.e. sampling started after 4, 5 and 6.5 hour for formulations containing 16%, 20% and 30% guar gum plug respectively). The composition for modified pulsatile device containing Glipizide Bilayer tablet and Glipizide microspheres is illustrated in the following 
RESULT AND DISCUSSIONS

Impermeable capsule body
Impermeable capsule body was successfully obtained. Formaldehyde treated empty capsules were evaluated for various parameters and results are as follows:-
Identification attributes:
They were no significant changes in the capsules except for the stickiness.
Visual defects:
In about 50 capsule bodies treated with formaldehyde five were found to shrink or distorted.
Dimensions:
The '0' size capsule bodies showed a significant decrease in length and diameter. The following measurements were taken before and after formaldehyde treatment of capsule body.
Average capsule length:
 
Solubility studies for the treated capsules:
The treated capsules were subjected to solubility studies for 24 hours in different buffers, the following observations were made:  In the case of normal capsules, both cap and body dissolved within 15 minutes.
 In the case of formaldehyde treated capsules, the cap dissolved within 15 minutes; whereas the capsule remained intact for about 24 hours. This was attributable to the cross linking of gelatin which prevented the disintegration of the capsule body.
Microspheres of glipizide
Microspheres were successfully prepared. The prepared microspheres were examined under an optical microscope. From SEM (Figure 02 ), it was observed that the prepared microspheres were spherical with smooth surface; might be due to complete homogeneity of drug and polymers. Eudragit microspheres had mean particle size of ranged between 30-55 μm; while the ethylcellulose microspheres were ranged between 38-61 μm.
Figure 2: Scanning Electron Micrographs of glipizide microspheres a) GL-1, b) GL-2, c) GL-3 and d) GL-4
Results of flow property, percentage yields and percentage drug content of glipizide microspheres are shown in table 4. All the formulations showed good flow properties. The value of the angle of repose between 21-28°θ indicates that the flow of the particles was reasonable and the microspheres were found to be fit in respect to flow ability and were thus suitable for further processing in the filling of the capsules. The mean percentage practical yield for all the formulation G M -1 to 4 was greater than 91%. It was observed that there was a positive correlation between the solid content and the percentage yield, which can be explained by the fact that, though a constant material is ISSN: 2250-1177 CODEN (USA): JDDTAO always lost in processing. This loss is proportionately less significant when the solid content is more. The drug content was found to be very high in all the cases i.e. all the formulations showed percentage drug content in the range of 96-98%. 
Bilayered tablet plugs
Bilayered Tablet Plugs were successfully prepared by direct compression method. Tablets were then stored in a desiccators over fused calcium chloride till further evaluations. The results of pre-compression studies are presented in table 5 table 6 . From erosion time, it was found Guar Gum disintegrate slowly and take more time to erode as compared to other formulations. Among all the formulations, formulations containing 16% Guar Gum tablet plugs erode fast than others because of less concentration of this polymer. It was observed as the concentration of polymer increases erosion time increases. The content of Glipizide in each preparation was assayed by UV spectroscopy. The drug content was found to be very high in all the cases in a range between 96.6 ± 0.1643% to 99.2 ± 0.0512%. The assay values were between 95% and 98% of the theoretical values. In vitro drug release studies were performed using USP-XXIII dissolution assembly. In vitro percentage drug release data are given in 
*Average ± SD of 3 determinations
Pulsatile (modified pulsincap) drug delivery system containing glipizide
Pulsatile drug delivery system of Anti-Diabetic Drug (Glipizide) was successfully prepared. All the formulated capsules passed the test since the percentage weight variation was within the pharmacopoeial limits.
In vitro dissolution profile of pulsincap formulations during 16 hours studies was found to have an efficient time controlled release of Glipizide. The drug release from the formulations was dependent on the type of hydrogel plug present in the Pulsincap device. The formulations with the plug with 30% Guar Gum showed more lag time 7 hours this was due to the higher viscosity of Guar Gum which swell slowly and to a greater extend producing a viscous gel which holds the capsule body for a longer time as compared to the hydrogel plugs containing 16% guar gum plugs which takes up water fast, disintegrates faster and showed less lag time of 4.5 hours.
During dissolution studies, it was observed that, after the releases of immediate dose of Glipizide (5 mg) from bilayered tablet plug in simulated gastric fluid; the exposed polymer plug start absorbing the surrounding fluids, swollen and released the drug through the swollen matrix. After complete wetting of the plug, it formed a soft mass and then easily ejected out of the capsule body; releasing the Glipizide microspheres into the simulated colonic fluid with pH 6.8. Among all the formulations, formulations containing Glipizide: Eudragit 0.5:1 microspheres (F G -7 to F G -9) showed slow drug releases after controlled lag time.
Based on the in vitro drug release data, considering the highest regression values the best fitting model for Glipizide in all formulations was Higuchi-Matrix with an exception of F G -9 where First order was the best fitting model for Glipizide.
Stability Studies
The results of stability studies of Glipizide Pulsatile drug delivery system showed no significant change with respect to physical appearance, drug content and in vitro drug release at the end of six months. Aging did not alter the drug release profiles of any of the formulations significantly at the end of the storage period.
CONCLUSION
In the present study, a time-controlled chronomodulated pulsatile drug delivery system of Glipizide containing an immediate release dose and Glipizide microspheres for sustained release of the drug after a desired lag time was successfully developed. It has been concluded from the investigation that pulsincap dosage form of glipizide could be effectively control the blood glucose levels throughout the day in respect to release of two pulses i.e. first pulse of immediate dose (equivalent to 5 mg Glipizide) after administration before breakfast and second pulse of sustained release microspheres (equivalent to 10 mg Glipizide) during noon which will maintain the drug concentration throughout the day till mid night. Hence it is considered to be suitable for the diabetic patient to manage postprandial blood glucose levels.
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